BRIC Dominate In Vitro Diagnostic Market (IVD) Global Growth Forecasts to 2017

DALLAS, July 28, 2014 /PRNewswire/ --

The In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 research report says global industry is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market.

In 2012, the Americas had accounted for the largest share of 41.8% in 2012 of the global IVD market. Europe was the second largest-market with the share of 31.0% in 2012. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Companies profiled in this IVD (in vitro diagnostics) market report to 2017 include Abbott Laboratories, Inc., Alere, Inc., Arkray, Inc., Bayer AG, Becton, Dickinson And Company, Biomerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, Diagnostica Stago Sas, Diasorin S.P.A., Hologic, Inc., Horiba, Ltd., Johnson & Johnson, Novartis International AG, Qiagen N.V., Roche Diagnostics Limited, Siemens Healthcare, Sysmex Corporation and Thermo Fisher Scientific, Inc. Buy a copy of In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 report at http://www.rnrmarketresearch.com/contacts/purchase?rname=108798 .

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018 is a June 2014 publication of 300 pages that says rising prevalence of major infectious diseases, introduction of reagents (molecular assays), and technological advancements (PCR, INAAT, and Microarray) are likely to drive the global molecular diagnostics market in the next five years. Companies profiled in this research include Abbott Diagnostics, Inc., Beckman Coulter, Inc., Becton, Dickinson & Co., Biomérieux Business Overview, Cepheid, Inc., Gen-Probe, Inc. (Hologic, Inc.), Novartis AG, Qiagen, Roche Diagnostics and Siemens Healthcare. Complete report is available at http://www.rnrmarketresearch.com/molecular-diagnostics-market-by-application-infectious-disease-oncology-genetics-microbiology-technology-pcr-inaat-dna-sequencing-end-user-hospital-laboratories-product-instruments-re-market-report.html .

Veterinary Diagnostics Market by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) - Global Forecast to 2018 is an April 2014 publication of 320 pages that says market is expected to grow at a healthy CAGR during the forecast period of 2013 to 2018 and is estimated to be worth $4,200 million by 2018. The market is mainly driven by the increasing incidences of disease outbreaks, increasing companion animal market backed by the rise in the adoption of pets, increase in the disposable incomes, and the increasing incidences of zoonotic diseases. However, economic downturn and increasing adoption of vegetarian food inhibits the growth of the market to a certain extent. Companies profiled in this research include Abaxis Corporation, Heska Corporation, Idexx Laboratories Inc., Idvet, Mindray Medical International Ltd., Neogen Corporation, Thermo Fisher Scientific Inc (Life Technologies + Prionics AG), VCA Antech, Virbac and Zoetis Inc. Complete report is available at http://www.rnrmarketresearch.com/veterinary-diagnostics-market-by-products-clinical-chemistry-hematology-analyzers-molecular-diagnostics-immunodiagnostics-diagnostics-imaging-by-animals-companion-food-producing-dog-livesto-market-report.html .

Explore more reports on in vitro diagnostics market (IVD) and general diagnostics industry at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics .

Table of Contents for In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 research report cover:

1 Introduction 23
1.1 Key Take-Aways 23
1.2 Report Description 23
1.3 Markets Covered 25
1.4 Stakeholders 27
1.5 Research Methodology 28
1.5.1 Market Size 28
1.5.2 Market Share 28
1.5.3 Key Data Points From Secondary Sources 29
1.5.4 Key Data Points From Primary Sources 29
1.5.5 Assumptions 29

2 Executive Summary 30 

3 Market Overview 32
3.1 Introduction 33
3.2 Market Segmentation 35
3.3 Market Dynamics 37
3.3.1 Drivers & Restraint 38
3.3.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Market 38
3.3.1.2 Rapidly Aging Population 39
3.3.1.3 Rise In Point-Of-Care (Poc) Testing 39
3.3.1.4 Personalized Medicine To Propel Growth 39
3.3.1.5 Lack Of Budget To Restrict Growth 40
3.3.2 Opportunities 40
3.3.2.1 Extending Reach Of Molecular Diagnostics 40
3.3.2.2 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics 41
3.3.3 Challenge 41
3.3.3.1 Stringent Regulatory Framework Acts As A Major Challenge 41
3.4 Winning Imperatives 41
3.4.1 Non-Proprietary System With Enhanced Functionalities 41
3.5 Burning Issues 42
3.5.1 Laboratory Automation For Increased Efficiency And Accurate Diagnosis 42
3.6 Market Share Analysis 43
3.7 Pestel Analysis 45
3.7.1 Political 45
3.7.2 Economic 47
3.7.3 Socio-Cultural 47
3.7.4 Technological 47
3.7.5 Environmental 48
3.7.6 Legal 48

4 Global Ivd Market, By Technique 49
4.1 Introduction 50
4.1.1 Clinical Chemistry 52
4.1.2 Immunochemistry 57
4.1.3 Hematology 62
4.1.4 Coagulation 67
4.1.5 Microbiology 72
4.1.6 Molecular Diagnostics 77
4.1.7 Other Clinical Instruments 82

5 Global Ivd Market, By Product Type 87
5.1 Introduction 88
5.2 Instruments 90
5.3 Reagents 95
5.4 Data Management System Software/Hardware 100
5.5 Services 104

6 Global Ivd Market, By Application 108
6.1 Introduction 109
6.2 Diabetes 111
6.3 Infectious Diseases 116
6.4 Oncology 121
6.5 Cardiology 126
6.6 Nephrology 131
6.7 Autoimmune Diseases 136
6.8 Drug Testing 141
6.9 Hiv/Aids 146
6.10 Others 151

7 Global Ivd Market, By End-User 155
7.1 Introduction 156
7.2 Laboratory 158
7.3 Hospitals 158
7.4 Academics 159
7.5 Point-Of-Care Testing 159
7.6 Patient Self-Testing 160
7.7 Others 160

8 Geographic Analysis 161
8.1 Introduction 162
8.2 Americas 165
8.2.1 U.S. 169
8.2.2 Canada 173
8.2.3 Mexico 176
8.2.4 Chile 180
8.2.5 Rest Of Americas (Roa) 183
8.3 Europe 187
8.3.1 Germany 191
8.3.2 France 194
8.3.3 Italy 198
8.3.4 Spain 201
8.3.5 U.K. 204
8.3.6 Rest Of Europe (Roe) 208
8.4 Japan 212
8.5 Bric 216
8.5.1 Brazil 219
8.5.2 Russia 223
8.5.3 India 227
8.5.4 China 231
8.6 Rest Of The World (Row) 236

9 Competitive Landscape 240
9.1 Introduction 240
9.2 New Product Launch 242
9.3 Agreements, Partnerships, Collaborations & Joint Ventures 254
9.4 Mergers And Acquisitions 266
9.5 Other Developments 273

10 Company Profiles 279
(Overview, Financials, Products & Services And Developments & Strategy)*
10.1 Abbott Laboratories, Inc. 279
10.2 Alere, Inc. 286
10.3 Arkray, Inc. 297
10.4 Bayer Ag 302
10.5 Becton, Dickinson And Company 306
10.6 Biomerieux 313
10.7 Bio-Rad Laboratories, Inc. 321
10.8 Danaher Corporation 329
10.9 Diagnostica Stago Sas 338
10.10 Diasorin S.P.A. 344
10.11 Hologic, Inc. 351
10.12 Horiba, Ltd. 356
10.13 Johnson & Johnson 361
10.14 Novartis International Ag 369
10.15 Qiagen N.V. 375
10.16 Roche Diagnostics Limited 381
10.17 Siemens Healthcare 390
10.18 Sysmex Corporation 402
10.19 Thermo Fisher Scientific, Inc. 409

*Details On Financials, Products & Services And Developments & Strategy Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables 

Table 1 Clinical Chemistry Market, By Geography, 2010 - 2017 ($Million) 53
Table 2 The Americas: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million) 54
Table 3 Europe: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million) 55
Table 4 Bric: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million) 56
Table 5 Global Clinical Chemistry Market, By Instruments & Reagents, 2010 - 2017 ($Million) 57
Table 6 Immunochemistry Market, By Geography, 2010 - 2017 ($Million) 58
Table 7 The Americas: Immunochemistry Market, By Country, 2010 - 2017 ($Million) 59
Table 8 Europe: Immunochemistry Market, By Country, 2010 - 2017 ($Million) 60
Table 9 Bric: Immunochemistry Market, By Country, 2010 - 2017 ($Million) 61
Table 10 Global Immunochemistry Market, By Instruments & Reagents, 2010 - 2017 ($Million) 62
Table 11 Hematology Market, By Geography, 2010 - 2017 ($Million) 63
Table 12 The Americas: Hematology Market, By Country, 2010 - 2017 ($Million) 64
Table 13 Europe: Hematology Market, By Country, 2010 - 2017 ($Million) 65
Table 14 Bric: Hematology Market, By Country, 2010 - 2017 ($Million) 66
Table 15 Global Hematology Market, By Instruments & Reagents, 2010 - 2017 ($Million) 67
Table 16 Coagulation Market, By Geography, 2010 - 2017 ($Million) 68
Table 17 The Americas: Coagulation Market, By Country, 2010 - 2017 ($Million) 69
Table 18 Europe: Coagulation Market, By Country, 2010 - 2017 ($Million) 70
Table 19 Bric: Coagulation Market, By Country, 2010 - 2017 ($Million) 71
Table 20 Global Coagulation Market, By Instruments & Reagents, 2010 - 2017 ($Million) 72
Table 21 Microbiology Market, By Geography, 2010 - 2017 ($Million) 73
Table 22 The Americas: Microbiology Market, By Country, 2010 - 2017 ($Million) 74
Table 23 Europe: Microbiology Market, By Country, 2010 - 2017 ($Million) 75
Table 24 Bric: Microbiology Market, By Country, 2010 - 2017 ($Million) 76
Table 25 Global Microbiology Market, By Instruments & Reagents, 2010 - 2017 ($Million) 77
Table 26 Molecular Diagnostics Market, By Geography, 2010 - 2017 ($Million) 78
Table 27 The Americas: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million) 79
Table 28 Europe: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million) 80
Table 29 Bric: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million) 81
Table 30 Global Molecular Diagnostics Market, By Instruments & Reagents, 2010 - 2017 ($Million) 82
Table 31 Other Ivd Techniques Market, By Geography, 2010 - 2017 ($Million) 83
Table 32 The Americas: Other Ivd Techniques Market, By Country, 2010 - 2017 ($Million) 84
Table 33 Europe: Other Ivd Techniques Market, By Country, 2010 - 2017 ($Million) 85
Table 34 Bric: Other Ivd Techniques Market, By Country, 2010 - 2017 ($Million) 86
Table 35 Global Ivd Market, By Product Type, 2010 - 2017 ($Million) 89
Table 36 Ivd Instruments Market, By Geography, 2010 - 2017 ($Million) 91
Table 37 The Americas: Ivd Instruments Market, By Country, 2010 - 2017 ($Million) 92
Table 38 Europe: Ivd Instruments Market, By Country, 2010 - 2017 ($Million) 93
Table 39 Bric: Ivd Instruments Market, By Country, 2010 - 2017 ($Million) 94
Table 40 Ivd Reagents Market, By Geography, 2010 - 2017 ($Million) 96
Table 41 The Americas: Ivd Reagents Market, By Country, 2010 - 2017 ($Million) 97
Table 42 Europe: Ivd Reagents Market, By Country, 2010 - 2017 ($Million) 98
Table 43 Bric: Ivd Reagents Market, By Country, 2010 - 2017 ($Million) 99
Table 44 Ivd Data Management System Software/Hardware Market, By Geography, 2010 - 2017 ($Million) 100
Table 45 The Americas: Ivd Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million) 101
Table 46 Europe: Ivd Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million) 102
Table 47 Bric: Ivd Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million) 103
Table 48 Ivd Services Market, By Geography, 2010 - 2017 ($Million) 104
Table 49 The Americas: Ivd Services Market, By Country, 2010 - 2017 ($Million) 105
Table 50 Europe: Ivd Services Market, By Country, 2010 - 2017 ($Million) 106
Table 51 Bric: Ivd Services Market, By Country, 2010 - 2017 ($Million) 107
Table 52 Global In-Vitro Diagnostics Market, By Application, 2010 - 2017 ($Million) 110
Table 53 Diabetes Ivd Market, By Geography, 2010 - 2017 ($Million) 112
Table 54 Americas: Diabetes Ivd Market, By Country, 2010 - 2017 ($Million) 113
Table 55 Europe: Diabetes Ivd Market, By Country, 2010 - 2017 ($Million) 114
Table 56 Bric: Diabetes Ivd Market, By Country, 2010 - 2017 ($Million) 115
Table 57 Infectious Diseases Ivd Market, By Geography, 2010 - 2017 ($Million) 117
Table 58 Americas: Infectious Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 118
Table 59 Europe: Infectious Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 119
Table 60 Bric: Infectious Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 120
Table 61 Oncology Ivd Market, By Geography, 2010 - 2017 ($Million) 122
Table 62 Americas: Oncology Ivd Market, By Country, 2010 - 2017 ($Million) 123
Table 63 Europe: Oncology Ivd Market, By Country, 2010 - 2017 ($Million) 124
Table 64 Bric: Oncology Ivd Market, By Country, 2010 - 2017 ($Million) 125
Table 65 Cardiology Ivd Market, By Geography, 2010 - 2017 ($Million) 127
Table 66 Americas: Cardiology Ivd Market, By Country, 2010 - 2017 ($Million) 128
Table 67 Europe: Cardiology Ivd Market, By Country, 2010 - 2017 ($Million) 129
Table 68 Bric: Cardiology Ivd Market, By Country, 2010 - 2017 ($Million) 130
Table 69 Nephrology Ivd Market, By Geography, 2010 - 2017 ($Million) 132
Table 70 Americas: Nephrology Ivd Market, By Country, 2010 - 2017 ($Million) 133
Table 71 Europe: Nephrology Ivd Market, By Country, 2010 - 2017 ($Million) 134
Table 72 Bric: Nephrology Ivd Market, By Country, 2010 - 2017 ($Million) 135
Table 73 Autoimmune Diseases Ivd Market, By Geography, 2010 - 2017 ($Million) 137
Table 74 America: Autoimmune Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 138
Table 75 Europe: Autoimmune Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 139
Table 76 Bric: Autoimmune Diseases Ivd Market, By Country, 2010 - 2017 ($Million) 140
Table 77 Drug Testing Ivd Market, By Geography, 2010 - 2017 ($Million) 142
Table 78 Americas: Drug Testing Ivd Market, By Country, 2010 - 2017 ($Million) 143
Table 79 Europe: Drug Testing Ivd Market, By Country, 2010 - 2017 ($Million) 144
Table 80 Bric: Drug Testing Ivd Market, By Country, 2010 - 2017 ($Million) 145
Table 81 Hiv/Aids Ivd Market, By Geography, 2010 - 2017 ($Million) 147
Table 82 Americas: Hiv/Aids Ivd Market, By Country, 2010 - 2017 ($Million) 148
Table 83 Europe: Hiv/Aids Ivd Market, By Country, 2010 - 2017 ($Million) 149
Table 84 Bric: Hiv/Aids Ivd Market, By Country, 2010 - 2017 ($Million) 150
Table 85 Other Applications Market, By Geography, 2010 - 2017 ($Million) 151
Table 86 America: Other Applications Market, By Country, 2010 - 2017 ($Million) 152
Table 87 Europe: Other Applications Market, By Country, 2010 - 2017 ($Million) 153
Table 88 Bric: Other Applications Market, By Country, 2010 - 2017 ($Million) 154
Table 89 Global Ivd Market, By End-User, 2010 - 2017 ($Million) 157
Table 90 In Vitro Diagnostics Market, By Geography, 2010 - 2017 ($Million) 164
Table 91 Americas: Ivd Market, By Country, 2010 - 2017 ($Million) 166
Table 92 Americas: Ivd Market, By Technique, 2010 - 2017 ($Million) 167
Table 93 Americas: Ivd Market, By Application, 2010 - 2017 ($Million) 168
Table 94 Americas: Ivd Market, By Product Type, 2010 - 2017 ($Million) 169
Table 95 U.S.: Ivd Market, By Technique, 2010 - 2017 ($Million) 171
Table 96 U.S.: Ivd Market, By Application, 2010 - 2017 ($Million) 172
Table 97 U.S.: Ivd Market, By Product Type, 2010 - 2017 ($Million) 173
Table 98 Canada: Ivd Market, By Technique, 2010 - 2017 ($Million) 174
Table 99 Canada: Ivd Market, By Application, 2010 - 2017 ($Million) 175
Table 100 Canada: Ivd Market, By Product Type, 2010 - 2017 ($Million) 176
Table 101 Mexico: Ivd Market, By Technique, 2010 - 2017 ($Million) 178
Table 102 Mexico: Ivd Market, By Application, 2010 - 2017 ($Million) 179
Table 103 Mexico: Ivd Market, By Product Type, 2010 - 2017 ($Million) 180
Table 104 Chile: Ivd Market, By Technique, 2010 - 2017 ($Million) 181
Table 105 Chile: Ivd Market, By Application, 2010 - 2017 ($Million) 182
Table 106 Chile: Ivd Market, By Product Type, 2010 - 2017 ($Million) 183
Table 107 Roa: Ivd Market, By Technique, 2010 - 2017 ($Million) 184
Table 108 Roa: Ivd Market, By Application, 2010 - 2017 ($Million) 185
Table 109 Roa: Ivd Market, By Product Type, 2010 - 2017 ($Million) 186
Table 110 Europe: Ivd Market, By Country, 2010 - 2017 ($Million) 188
Table 111 Europe: Ivd Market, By Technique, 2010 - 2017 ($Million) 189
Table 112 Europe: Ivd Market, By Application, 2010 - 2017 ($Million) 190
Table 113 Europe: Ivd Market, By Product Type, 2010 - 2017 ($Million) 191
Table 114 Germany: Ivd Market, By Technique, 2010 - 2017 ($Million) 192
Table 115 Germany: Ivd Market, By Application, 2010 - 2017 ($Million) 193
Table 116 Germany: Ivd Market, By Product Type, 2010 - 2017 ($Million) 194
Table 117 France: Ivd Market, By Technique, 2010 - 2017 ($Million) 195
Table 118 France: Ivd Market, By Application, 2010 - 2017 ($Million) 196
Table 119 France: Ivd Market, By Product Type, 2010 - 2017 ($Million) 197
Table 120 Italy: Ivd Market, By Technique, 2010 - 2017 ($Million) 199
Table 121 Italy: Ivd Market, By Application, 2010 - 2017 ($Million) 200
Table 122 Italy: Ivd Market, By Product Type, 2010 - 2017 ($Million) 201
Table 123 Spain: Ivd Market, By Technique, 2010 - 2017 ($Million) 202
Table 124 Spain: Ivd Market, By Application, 2010 - 2017 ($Million) 203
Table 125 Spain: Ivd Market, By Product Type, 2010 - 2017 ($Million) 204
Table 126 U.K.: Ivd Market, By Technique, 2010 - 2017 ($Million) 206
Table 127 U.K.: Ivd Market, By Application, 2010 - 2017 ($Million) 207
Table 128 U.K.: Ivd Market, By Product Type, 2010 - 2017 ($Million) 208
Table 129 Roe: Ivd Market, By Technique, 2010 - 2017 ($Million) 209
Table 130 Roe: Ivd Market, By Application, 2010 - 2017 ($Million) 210
Table 131 Roe: Ivd Market, By Product Type, 2010 - 2017 ($Million) 211
Table 132 Japan: Ivd Market, By Technique, 2010 - 2017 ($Million) 213
Table 133 Japan: Ivd Market, By Application, 2010 - 2017 ($Million) 214
Table 134 Japan: Ivd Market, By Product Type, 2010 - 2017 ($Million) 215
Table 135 Bric: Ivd Market, By Country, 2010 - 2017 ($Million) 216
Table 136 Bric: Ivd Market, By Technique, 2010 - 2017 ($Million) 217
Table 137 Bric: Ivd Market, By Application, 2010 - 2017 ($Million) 218
Table 138 Bric: Ivd Market, By Product Type, 2010 - 2017 ($Million) 219
Table 139 Brazil: Ivd Market, By Technique, 2010 - 2017 ($Million) 221
Table 140 Brazil: Ivd Market, By Application, 2010 - 2017 ($Million) 222
Table 141 Brazil: Ivd Market, By Product Type, 2010 - 2017 ($Million) 223
Table 142 Russia: Aging Population (Thousand) 224
Table 143 Russia: Ivd Market, By Technique, 2010 - 2017 ($Million) 225
Table 144 Russia: Ivd Market, By Application, 2010 - 2017 ($Million) 226
Table 145 Russia: Ivd Market, By Product Type, 2010 - 2017 ($Million) 227
Table 146 India: Ivd Market, By Technique, 2010 - 2017 ($Million) 229
Table 147 India: Ivd Market, By Application, 2010 - 2017 ($Million) 230
Table 148 India: Ivd Market, By Product Type, 2010 - 2017 ($Million) 231
Table 149 China: Ivd Market, By Technique, 2010 - 2017 ($Million) 233
Table 150 China: Ivd Market, By Application, 2010 - 2017 ($Million) 234
Table 151 China: Ivd Market, By Product Type, 2010 - 2017 ($Million) 235
Table 152 Row: Ivd Market, By Technique, 2010 - 2017 ($Million) 237
Table 153 Row: Ivd Market, By Application, 2010 - 2017 ($Million) 238
Table 154 Row: Ivd Market, By Product Type, 2010 - 2017 ($Million) 239
Table 155 New Product Launch, 2011 - 2013 242
Table 156 Agreements, Partnerships, Collaborations & Joint Ventures, 2011 - 2013 254
Table 157 Mergers & Acquisitions, 2011 - 2013 266
Table 158 Othere Developments, 2011 - 2013 273
Table 159 Abbott Laboratories, Inc.: Major Developments, 2011 - 2013 284
Table 160 Alere, Inc.: Major Developments, 2011 - 20113 295
Table 161 Arkray, Inc.: Major Developments, 2011 - 2013 300
Table 162 Bayer Ag: Major Developments, 2011 - 2013 305
Table 163 Becton, Dickinson And Company: Major Developments, 2011 - 2013 311
Table 164 Biomerieux: Major Developments, 2011 - 2012 319
Table 165 Bio-Rad Laboratories, Inc.: Major Developments, 2011 - 2012 327
Table 166 Danaher Corporation: Major Developments, 2011 - 2013 336
Table 167 Diagnostica Stago Sas: Major Developments, 2011 - 2013 342
Table 168 Diasorin Inc.: Major Developments, 2011 - 2013 348
Table 169 Hologic, Inc.: Major Developments, 2011 - 2013 354
Table 170 Horiba, Ltd.: Major Developments, 2011 - 2012 359
Table 171 Johnson & Johnson: Major Developments, 2011 - 2012 367
Table 172 Novartis Ag: Major Developments, 2011 - 2012 373
Table 173 Qaigen N.V.: Major Developments, 2011 - 2013 379
Table 174 Roche Holdings: Major Developments, 2011 - 2013 387
Table 175 Siemens Healthcare: Major Developments, 2011 - 2013 397
Table 176 Sysmex Corporation: Major Developments, 2011 - 2013 406
Table 177 Thermo Fisher Scientific, Inc.: Major Developments, 2011 - 2013 415

List Of Figures 

Figure 1 Global In-Vitro Diagnostic Instrument & Reagents Market, By Technique, 2012 ($Million) 30
Figure 2 Role Of Ivd In Healthcare 34
Figure 3 In Vitro Diagnostics Market Segmentation 36
Figure 4 In Vitro Diagnostics Market-Drivers & Restraints 37
Figure 5 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2012 44
Figure 6 Ivd Market: Pestel Analysis 46
Figure 7 Global In Vitro Diagnostics Market Segmentation, By Technique 50
Figure 8 Global In Vitro Diagnostics Market, By Technique 51
Figure 9 Global In Vitro Diagnostics Market, By Geography, 2012 163
Figure 10 Key Growth Strategies, 2011 - 2013 241
Figure 11 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million) 280
Figure 12 Abbott Laboratories, Inc.: Market Strategy, 2011 - 2013 283
Figure 13 Alere, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million) 287
Figure 14 Alere, Inc.: Professional Diagnostics Revenue, By Segment, 2011 - 2012 ($Million) 288
Figure 15 Alere, Inc.: Market Strategy, 2011 - 2013 294
Figure 16 Arkray, Inc.: Market Strategy, 2011 - 2012 299
Figure 17 Bayer Ag: Total Revenue, By Segment, 2010 - 2012 ($Million) 303
Figure 18 Becton, Dickinson And Company: Total Revenue, By Segment, 2010 - 2012 ($Million) 307
Figure 19 Bd Diagnostics: Total Revenue, By Segment, 2010 - 2012 ($Million) 308
Figure 20 Becton, Dickinson And Company: Market Strategy, 2011 - 2013 310
Figure 21 Biomerieux: Total Revenue, By Segment, 2010 - 2011 ($Million) 314
Figure 22 Biomerieux: Market Strategy, 2011 - 2012 318
Figure 23 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million) 322
Figure 24 Bio-Rad Laboratories, Inc.: Market Srategy, 2011 - 2013 326
Figure 25 Danaher Corporation: Total Revenue, By Segment, 2010 - 2012 ($Million) 330
Figure 26 Danaher Corporation: Market Strategy, 2011 - 2013 335
Figure 27 Diagnostica Stago Sas: Market Strategy, 2011 - 2013 341
Figure 28 Diasorin S.P.A.: Total Revenue, By Technology, 2010 - 2012, ($Million) 345
Figure 29 Diasorin S.P.A,: Market Strategy, 2011 - 2013 347
Figure 30 Hologic, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million) 352
Figure 31 Hologic, Inc.: Market Srategy, 2011 - 2013 354
Figure 32 Horiba Ltd.: Total Revenue, By Segments, 2009 - 2011 357
Figure 33 Horiba, Ltd.: Market Strategy, 2011 - 2013 359
Figure 34 Johnson & Johnson: Total Revenue, By Segment, 2010 - 2012 ($Milllion) 362
Figure 35 Johnson & Johnson: Diagnostics Franchise Revenue, 2010 - 2012 ($Million) 363
Figure 36 Johnson & Johnson: Market Strategy, 2011 - 2013 366
Figure 37 Novartis Ag: Total Revenue, By Segment, 2010 - 2012 370
Figure 38 Novartis Ag: Market Stretegy, 2011 - 2013 372
Figure 39 Qiagen N.V.: Total Revenue, By Segment, 2010 - 2012 ($Million) 376
Figure 40 Qiagen N.V.: Market Srategy, 2011 - 2013 378
Figure 41 Roche Holdings: Diagnostics Revenue, By Segment, 2010 - 2012 ($Million) 382
Figure 42 Roche Holdings: Diagnostics Revenue, By Geography, 2010 - 2012 ($Million) 383
Figure 43 Roche Holdings: Market Strategy, 2011 - 2012 386
Figure 44 Siemens Ag: Total Revenue, By Segment, 2010 - 2012 ($Million) 391
Figure 45 Siemens Healthcare: Market Strategy, 2011 - 2013 396
Figure 46 Sysmex Corporation: Diagnostics Segment Revenue, 2010 - 2012 ($Million) 403
Figure 47 Sysmex Corporation: Market Strategy, 2011 - 2013 406
Figure 48 Thermo Fisher Scientific, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million) 410
Figure 49 Thermo Fisher Scientific, Inc.: Market Srategy, 2011 - 2013 414

About Us 

RnR Market Research is an online database of syndicated market research reports covering over 5000 micro markets including life sciences and its multiple sectors like biotechnology. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact: 

Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
sales@rnrmarketresearch.com

http://www.reportsnreports.com/publisher/marketsandmarkets/

Connect With Us on: 

Facebook: http://www.facebook.com/pages/RnR-Market-Research/413488545356345

Twitter: https://twitter.com/#!/RnRMR

G+ / Google Plus: https://plus.google.com/u/0/104156468549256253075/ 

Market Research Reports Index: http://www.rnrmarketresearch.com/report-index 

RSS Feed: http://www.rnrmarketresearch.com/feed